A novel RA-inhibited target is the matricellular protein Smoc2, whose mutation in human produces oligodontia, microdontia, abnormal root development, dentin dyplasia, and reduced alveolar bone growth (Bloch-Zupan et al., 2011). This evidence concerns the gene SMOC2 and Oligodontia.